Results 211 to 220 of about 54,143 (283)

Efficacy and safety of disitamab vedotin (RC48) combined with camrelizumab and S‐1 for neoadjuvant therapy of locally advanced gastric cancer with HER2‐overexpressing: Preliminary results of a prospective, single‐arm, phase II study

Clinical and Translational Medicine, Volume 16, Issue 5, May 2026.
Neoadjuvant disitamab vedotin combined with camrelizumab and S‐1 achieved high pathological response rates with manageable safety in resectable HER2‐overexpressing gastric and gastroesophageal junction cancer. Longitudinal circulating tumour DNA methylation profiling enabled dynamic monitoring of molecular response during treatment.
Longgang Wang, Bing Liu, Luguang Liu, Liqing Liu, Rong Li, Shumei Han, Xu Sun, Bo Bi, Yuanlin Sun, Dong Sun, Jie Chai   +10 more
wiley   +1 more source

The use of three-dimensional imaging for R0 resection of a left upper lobe adenocarcinoma after coronary artery bypass surgery. [PDF]

JTCVS Tech, 2022
Shamir S, Lazzaro RS, Inra ML.
europepmc   +1 more source

Survival outcomes and prognostic factors of gastric carcinoma with neuroendocrine differentiation

International Journal of Cancer, Volume 158, Issue 9, Page 2209-2218, 1 May 2026.
What's new? Although gastric carcinoma with neuroendocrine differentiation (GCNED) is associated with more aggressive features than conventional GC, its prognosis and survival remain poorly defined. To better understand survival patterns, the authors of the present study examined clinicopathological and prognostic features of GCNED patients following ...
Jinjin Li, Chenglong Wang, Yifan Shen, Zhen Huang, Jun Zhang, Siqi Rao, Youde Cao, Jiang Min   +7 more
wiley   +1 more source

Long-term prognostic significance of ascites cytology in ovarian cancer cases in which R0 resection was achieved in the initial surgery: a multi-institutional retrospective cohort study. [PDF]

Jpn J Clin Oncol
Iyoshi S, Sunohara M, Yoshihara M, Kunishima A, Miyamoto E, Fujimoto H, Kitami K, Mogi K, Uno K, Yoshida K, Tamauchi S, Yokoi A, Niimi K, Yoshikawa N, Emoto R, Matsui S, Kajiyama H.   +16 more
europepmc   +1 more source

Pouch Surgery for Ulcerative Colitis: Navigating Complexity in the Modern Era

JCC Plus, Volume 1, Issue 3, May 2026.
ABSTRACT Restorative proctocolectomy with ileal pouch–anal anastomosis (IPAA) remains the preferred surgical treatment for patients with ulcerative colitis (UC) who require surgery but wish to avoid a permanent ileostomy. Since its introduction in 1978, IPAA has undergone continuous refinement in response to advances in both medical therapy and ...
Gabriele Bislenghi, Caroline Nordenvall, Anthony de Buck van Overstraeten, Peter Kienle, Alaa El‐Hussuna   +4 more
wiley   +1 more source

Case report: a R0 resection successfully induced by T-DXd plus PD-1 inhibitor regimen in a primary unresectable stage IIIB NSCLC with ERBB2-mutation. [PDF]

NPJ Precis Oncol
Zhang R, Cheng S, Sun K, Zhang L, Yan X, Yang F.   +5 more
europepmc   +1 more source

Laryngeal Transplantation in Cancer Patients: Evaluation of Surgical Outcomes and Functional Recovery

MedComm, Volume 7, Issue 5, May 2026.
Our pilot clinical study in laryngeal transplantation achieved divergent outcomes: two cases maintained functional speech/swallowing with around 2 year graft survival and have been ongoing, while two succumbed to sepsis (10mo) and hemorrhagic recurrence (11mo).
Zheng Jiang, Mailudan Ainiwaer, Pengwei Zhao, Yansheng Hu, Xin Yang, Yu Xiong, Bin Zeng, Longhao Wang, Jun Liu, Fei Chen   +9 more
wiley   +1 more source

Abdominal parietal metastasis on operative scar of gastric adenocarcinoma after R0 resection: An unusual location (about a case). [PDF]

Int J Surg Case Rep
Ahue KHN, Keita M, Goho KM, N'Guessan Saint-Blanc Yapo I, Adon AA, Coulibaly NA.   +5 more
europepmc   +1 more source

Rethinking Invasive Mediastinal Staging in the Era of Neoadjuvant Immune‐Checkpoint Inhibitors

Thoracic Cancer, Volume 17, Issue 9, May 2026.
As neoadjuvant immunotherapy reshapes resectability in NSCLC, the role of invasive mediastinal staging is being fundamentally reconsidered—with implications for risk stratification, patient selection, and trial design. ABSTRACT Over the past several decades, the management of nonmetastatic nonsmall cell lung cancer (NSCLC) has centered on identifying ...
Saulo Brito Silva, Danilo Tadao Wada, Lycio Umeda Dessotte, Li Siyuan Wada, Adilson Aparecido Faccio, Federico Garcia Cipriano   +5 more
wiley   +1 more source

Correction to: R0 resection of linitis plastica of the stomach with synchronous bilateral Krukenberg tumours in a young woman. [PDF]

J Surg Case Rep
europepmc   +1 more source